Published in Int Clin Psychopharmacol on November 01, 1993
Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet (2000) 3.05
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group. J Clin Psychiatry (1999) 1.64
Kinetic basis for insensitivity to tetrodotoxin and saxitoxin in sodium channels of canine heart and denervated rat skeletal muscle. Biochemistry (1987) 1.60
An emerging pharmacology of peptide toxins targeted against potassium channels. J Membr Biol (1988) 1.59
Zn2(+)-induced subconductance events in cardiac Na+ channels prolonged by batrachotoxin. Current-voltage behavior and single-channel kinetics. J Gen Physiol (1991) 1.31
Analysis of the blocking activity of charybdotoxin homologs and iodinated derivatives against Ca2+-activated K+ channels. J Membr Biol (1989) 1.16
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial. Acta Psychiatr Scand Suppl (1990) 1.05
Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry (1999) 1.03
Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci (1995) 0.97
Role of phosphorylation in desensitization of acetylcholine receptors expressed in Xenopus oocytes. J Neurosci (1994) 0.95
Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet (2000) 0.95
Low temperature sustains inhibition of angiotensin-converting-enzyme activity in serum from patients taking captopril. N Engl J Med (1981) 0.93
An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder. J Psychiatry Neurosci (2000) 0.92
Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease. Redox Rep (2005) 0.92
Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry (1997) 0.92
Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Pharmacopsychiatry (2000) 0.90
Celastrus paniculatus seed oil and organic extracts attenuate hydrogen peroxide- and glutamate-induced injury in embryonic rat forebrain neuronal cells. Phytomedicine (2005) 0.87
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res (1997) 0.87
Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res (1999) 0.86
A comparison of placebo responders and nonresponders in subgroups of depressive disorder. J Psychiatry Neurosci (1995) 0.86
Characterization of recombinant GABAA receptors produced in transfected cells from murine alpha 1, beta 1, and gamma 2 subunit cDNAs. Neurosci Lett (1991) 0.85
Alcohol withdrawal concealing symptoms of subdural hematoma--a caveat. Psychiatr J Univ Ott (1990) 0.85
Serotonergic genes and suicidality. Crisis (2001) 0.83
Modelling the cost effectiveness of antidepressant treatment in primary care. Pharmacoeconomics (1995) 0.83
A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression. J Clin Psychopharmacol (1998) 0.83
Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial. Psychol Med (2008) 0.82
Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients. J Psychiatry Neurosci (1993) 0.82
Manic psychosis associated with procarbazine. Br Med J (Clin Res Ed) (1982) 0.82
Two-tone suppression in auditory nerve of the cat: rate-intensity and temporal analyses. J Acoust Soc Am (1978) 0.82
Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. J Affect Disord (2001) 0.82
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder. J Affect Disord (1999) 0.81
Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial. J Clin Psychopharmacol (1999) 0.81
Preparatory brain potentials in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.81
Multiple saxitoxin-binding sites in bullfrog muscle: tetrodotoxin-sensitive sodium channels and tetrodotoxin-insensitive sites of unknown function. Mol Pharmacol (1988) 0.80
Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors. Acta Psychiatr Scand (2005) 0.79
The patterns of mental disorder in Jewish and non-Jewish admissions to a district general hospital psychiatric unit: is manic-depressive illness a typically Jewish disorder? Psychol Med (1983) 0.79
Event-related potentials and selective attention in major depressive illness. J Affect Disord (1991) 0.79
Manic-like response to phototherapy. Can J Psychiatry (1991) 0.78
Combined SSRI-moclobemide treatment of psychiatric illness. J Clin Psychiatry (1994) 0.78
Cis- and trans-isomers of doxepin and desmethyldoxepin in the plasma of depressed patients treated with doxepin. Ther Drug Monit (1990) 0.78
SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients. Int Clin Psychopharmacol (1995) 0.78
Synthesis and characterization of an aryl-azidoparoxetine. A novel photo-affinity probe for serotonin-transporter. Biochem Pharmacol (1995) 0.77
Turner syndrome diagnosed in northeastern Malaysia. Singapore Med J (2008) 0.77
Brainstem evoked potentials in panic disorder. J Psychiatry Neurosci (1994) 0.77
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. J Affect Disord (1994) 0.77
Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.76
Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder. Anxiety (1996) 0.76
Quantitative EEG correlates of panic disorder. Psychiatry Res (1996) 0.76
Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients. J Psychiatry Neurosci (1991) 0.75
Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies. Clin Neuropharmacol (1993) 0.75
Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studies. Clin Neuropharmacol (1992) 0.75
Systemic lupus erythematosus presenting as morbid jealousy. Postgrad Med J (1980) 0.75
Thiamine, riboflavin and pyridoxine deficiency in psychiatric in-patients. Br J Psychiatry (1982) 0.75
A dose-finding study with remoxipride in the acute treatment of schizophrenic patients. J Psychiatry Neurosci (1992) 0.75
ECNP position paper on social phobia proceedings from an ECNP workshop in Jerusalem, October 1994. Eur Neuropsychopharmacol (1996) 0.75
Jack fruit lectin binding pattern in carcinoma of the uterine cervix. J Exp Pathol (1990) 0.75
Association of ethnicity with antipsychotic dosage using STRUCTURE analysis. Pharmacopsychiatry (2013) 0.75
Demonstration of a tumour associated antigen in human oral cancers. Indian J Med Res (1981) 0.75
Motor paralytic bladder. J Assoc Physicians India (1986) 0.75
The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia. J Clin Psychopharmacol (1994) 0.75
A comparison of placebo response with major depressive disorder in patients recruited through newspaper advertising versus consultation referrals. Psychopharmacol Bull (1997) 0.75
Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder. Psychopharmacol Bull (1994) 0.75
Emphysematous urinoma in a renal transplant patient. Am J Kidney Dis (2001) 0.75
Disulfiram and bipolar affective disorder: a case report. J Clin Psychopharmacol (1986) 0.75
Myalgia with the new generation antidepressants. J Clin Psychopharmacol (1986) 0.75
A comparison of patients with major depressive disorder recruited through newspaper advertising versus consultation referrals for clinical drug trials. Psychopharmacol Bull (1997) 0.75
Alternating electrical-resistance changes in the guinea-pig cochlea caused by acoustic stimuli. J Acoust Soc Am (1977) 0.75
Relaxation-induced EEG alterations in panic disorder patients. J Anxiety Disord (1997) 0.75
A time series aggregation model for predicting the incidence of syphilis. Sex Transm Dis (1979) 0.75
Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin. Int Clin Psychopharmacol (1988) 0.75